Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety of Fluarix™/ Influsplit SSW® 2010/2011 or Pandemrix™

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01160237
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:24.306998+00:00
Published At
2012-03-23T00:00:00+00:00
Record Updated At
2016-10-20
Results Posted At
2012-03-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Influenza"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-10-20"
protocolSection.identificationModule.nctId
"NCT01160237"
protocolSection.identificationModule.officialTitle
"Immunogenicity and Safety of Fluarix\u2122/ Influsplit SSW\u00ae 2010/2011 or Pandemrix\u2122"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2012-03-23"

Study condition terms

  • Influenza (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.